₹1,378.25-17.20 (-1.23%)
20-Dec-2024₹1,380.30-13.80 (-0.99%)
20-Dec-2024BSE : 540596
NSE : ERIS
Sector : Health care
ISIN Code : INE406M01024
Last Updated: 20-Dec-2024
Market Cap (₹ Cr) | 18,758 |
Traded Value (₹ Cr) | 1.14 |
Volume (Shares) | 8,259 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,593.00 |
52-Week High Date | 11-Dec-2024 |
52-Week Low (₹) | 810.10 |
52-Week Low Date | 13-Mar-2024 |
All Time High (₹) | 1,593.00 |
All Time High Date | 11-Dec-2024 |
All Time Low (₹) | 341.05 |
All Time Low Date | 30-Mar-2020 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 18,786 |
EPS - TTM (₹) [C] | 25.60 |
P/E Ratio (X) [C] | 53.92 |
Face Value (₹) | 1 |
Latest Dividend (%) | 735.00 |
Latest Dividend Date | 11-Aug-2022 |
Dividend Yield (%) | - |
Book Value Share (₹) [C] | 203.59 |
P/B Ratio (₹) [C] | 6.78 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Franklin India Pension Plan - (G) | 3.44 | 23,500 | 0.66 |
Franklin India Pension Plan - (IDCW) | 3.44 | 23,500 | 0.66 |
Franklin India Pension Plan - Direct (G) | 3.44 | 23,500 | 0.66 |
Franklin India Pension Plan - Direct (IDCW) | 3.44 | 23,500 | 0.66 |
ICICI Pru All Seasons Bond Fund - Regular (IDCW-W) | 105.22 | 10,450 | 0.78 |
ICICI Pru All Seasons Bond Fund - Regular (G) | 105.22 | 10,450 | 0.78 |
ICICI Pru All Seasons Bond Fund - Regular (IDCW) | 105.22 | 10,450 | 0.78 |
ICICI Pru All Seasons Bond Fund - Regular (IDCW-A) | 105.22 | 10,450 | 0.78 |
ICICI Pru All Seasons Bond Fund - Regular (IDCW-Q) | 105.22 | 10,450 | 0.78 |
ICICI Pru All Seasons Bond Fund - Direct (G) | 105.22 | 10,450 | 0.78 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
18-May-2023 | Prabhudas Lilladher | Buy | 780 | |
17-Mar-2023 | Prabhudas Lilladher | Buy | 780 | |
19-Jan-2023 | Prabhudas Lilladher | Buy | 850 |
Today's Low/High (₹) | 1,365.00 1,406.50 |
Week Low/High (₹) | 1,365.00 1,516.00 |
Month Low/High (₹) | 1,341.05 1,594.00 |
Year Low/High (₹) | 809.15 1,594.00 |
All time Low/High (₹) | 341.05 1,594.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -5.94% | -5.78% | -4.98 | -4.77% |
1 Month | 1.17% | 0.87% | 0.60 | 0.29% |
3 Month | 1.49% | 1.00% | -7.69 | -8.54% |
6 Month | 33.78% | 33.78% | 0.73 | 0.09% |
1 Year | 57.96% | 57.77% | 10.69 | 11.52% |
3 Year | 100.30% | 99.74% | 39.80 | 41.97% |
Chairman & Managing Director : Amit Indubhushan Bakshi
Whole-time Director : Kaushal Kamlesh Shah
Whole-time Director : Inderjeet Singh Negi
Whole Time Director & COO : Krishnakumar Vaidyanathan
Independent Non Exe. Director : Sujesh Vasudevan
Independent Non Exe. Director : Prashant Gupta
Independent Non Exe. Director : Rajeev Narotam Dalal
Independent Non Exe. Director : Kalpana Unadkat
Company Sec. & Compli. Officer : Milind Talegaonkar
Registered Office: 8th Floor Commerce House -IV, Prahladnagar 100 FT Road,Ahmedabad,Gujarat-380015 Ph: 91-79-30451000
1. What's the ERIS Lifesciences Ltd share price today?
ERIS Lifesciences Ltd share price was Rs 1,378.25 at close on 20th Dec 2024. ERIS Lifesciences Ltd share price was down by 1.23% from the previous closing price of Rs 1,395.45. ERIS Lifesciences Ltd share price trend:
2. How can I quickly analyse the performance of the ERIS Lifesciences Ltd stock?
The performance of the ERIS Lifesciences Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of ERIS Lifesciences Ltd?
ERIS Lifesciences Ltd has a market capitalisation of Rs 18,758 crore.
4. What is ERIS Lifesciences Ltd's 52-week high/low share price?
The ERIS Lifesciences Ltd’s 52-week high share price is Rs 1,593.00 and 52-week low share price is Rs 810.10.
5. Is the ERIS Lifesciences Ltd profitable?
On a consolidated basis, ERIS Lifesciences Ltd reported a profit of Rs 28.10 crore on a total income of Rs 442.37 crore for the quarter ended 2024. For the year ended Sep 2024, ERIS Lifesciences Ltd had posted a profit of Rs 96.35 crore on a total income of Rs 745.72 crore.
6. Which are ERIS Lifesciences Ltd’s peers in the Health care sector?
ERIS Lifesciences Ltd’s top 5 peers in the Health care sector are Concord Biotech, Pfizer, Alembic Pharma, ERIS Lifescience, Neuland Labs., Caplin Point Lab, Jubilant Pharmo.
7. Who owns how much in ERIS Lifesciences Ltd?
Key changes to the ERIS Lifesciences Ltd shareholding are as follows: